ALSA Ventures

Venture capital investor in biotechnology companies passionate about bringing novel therapies to patients

[ALSA Ventures @AlsaVentures]

Congratulations to portfolio company Montis Biosciences for being awarded a #VLAIO #grant, which will be used to support the innovative work they are doing in immune-oncology.

Read more about it here: https://t.co/rWy4vYsCBR

#biotech #oncology #innovation #funding

[ALSA Ventures @AlsaVentures]

Read our latest blog post on how #COVID-19 has impacted allocation of venture capital in biotech here: https://t.co/nfMnEzsBkp
#biotech #investing #venturecapital

[ALSA Ventures @AlsaVentures]

Congratulations to Prof. Peter Carmeliet, one of the academic #founders of portfolio company Montis Biosciences , for being elected as an International Honorary Member of the prestigious American Academy of Arts & Sciences (#AAAS)
https://t.co/48aUPuNImD

[ALSA Ventures @AlsaVentures]

Rene Hoet joins the Montis Biosciences team as CSO, bringing extensive experience in #antibody drug discovery and development

Read more about it here: https://t.co/sKX6060uax

#oncology #innovation #biotech

[ALSA Ventures @AlsaVentures]

We are delighted to announce the launch of Promatix Inc, an ALSA Group company that is using multi-omics to develop the next generation of cancer therapeutics.
Read more about it on the website here: https://t.co/1Z5vn9JZ51
#proteomics #multiomics #oncology #innovation #biotech